Navigation Links
Trinity Biotech Investor Group Initiates Campaign of ADR Conversion to Force a Special Meeting of Shareholders
Date:11/11/2008

KANSAS CITY, Mo., Nov. 11 /PRNewswire/ -- An investor group in Trinity Biotech plc (Nasdaq: TRIB), an Irish based developer and manufacturer of diagnostic products whose shares are traded in the form of American Depository Receipts ("ADRs") on NASDAQ, has initiated a campaign for conversion of company ADRs to ordinary shares to bring about a special meeting of shareholders to consider a change in the board.

This campaign follows the recent refusal by Trinity Biotech directors to honor an earlier request by a group of ADR holders for the calling of a special meeting of shareholders to consider the removal and replacement of the company's current directors. The directors' rejection of the request was based on their determination that ADRs have fewer rights under Irish law than the ordinary shares into which they may be converted. The directors also refused to take alternative steps proposed by the requesting group to convene the meeting.

Commenting on the campaign, Tom Reidy stated, "The directors' blatant disregard for our basic rights as owners of the company has only heightened our resolve to impose accountability on company management. We are calling on all ADR holders who believe that a board change is in order to join with us in converting ADRs to ordinary shares. While none of us should be forced to take this unnecessary step, we believe this is the only way we can protect our investment."

Important Next Steps: ADR holders who would like assistance in converting their ADRs should contact Mr. Reidy at tjreidy3@hotmail.com or (816) 260-8476.


'/>"/>
SOURCE KC Investor Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Trinity Biotech Management Refuses to Honor Call for a Special Meeting of Shareholders
2. Investor Call Scheduled to Discuss Ouster Proposal of Trinity Biotech Directors
3. Trinity Biotech plc to Announce Third Quarter 2008 Financial Results on October 31, 2008
4. Trinity Biotech plc to Announce Second Quarter 2008 Financial Results on July 22, 2008
5. Video: Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck
6. Idenix Pharmaceuticals to Present at Deutsche Banks 2008 Biotech Boston Confab
7. Yongye Biotechnology to Present at Roth Capital China Comes to Vegas Conference
8. InterMune to Present at Deutsche Bank Biotech Boston Confab
9. InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces $1.25 Million Private Placement
10. Media Advisory - Oncolytics Biotech Inc. to Present at Rodman & Renshaw 10th Annual Healthcare Conference
11. Oncolytics Biotech Inc. Investigators Present Interim U.S. REOLYSIN(R) Phase II Sarcoma Trial Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... The report "Acrylic Processing Aid Market by Polymer Type (PVC), Fabrication Process (Extrusion, Injection Molding), ... 2026", published by MarketsandMarkets, the global market size was USD 645.4 Million in ... of CAGR of 6.2% between 2016 and 2026. ... ... , , ...
(Date:12/7/2016)... , Dec. 7, 2016  Muse bio, a privately-held ... today announced that Dr. Kevin Ness has ... Board of Directors. Kevin succeeds Muse ... the company,s Chief Science Officer as well as remains ... of the BioDesign Center at the RAS Energy Institute ...
(Date:12/7/2016)... CA (PRWEB) , ... December 07, 2016 , ... ... wastewater treatment and resource recovery solutions for industrial facilities, today announced that one ... be the first to use Cambrian’s novel water-energy purchase agreement (WEPA). Under the ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... early access program for SmartBiome -- a novel metagenomic deep-sequencing research platform. ... enrichment and detection of hundreds of different genes. The selective early access ...
Breaking Biology Technology:
(Date:12/7/2016)... Israel , December 7, 2016 BioCatch ... the expansion of its patent portfolio, which grew to over 40 granted ... , , ... its recently filed patent entitled " System, Device, and Method ... technology that enables device makers to forego costly hardware components needed to ...
(Date:12/6/2016)... 2016 Valencell , the leading innovator ... seen a third consecutive year of triple digit growth ... 2016 with a 360 percent increase in companies who ... was driven by sales of its wrist and ear ... its technology for hearables for fitness and healthcare applications. ...
(Date:12/2/2016)... 1, 2016   SoftServe , a global ... , an electrocardiogram (ECG) biosensor analysis system for ... IoT asset. The smart system ensures device-to-device communication ... wheel and mobile devices to easily ,recognize, and ... As vehicle technology advances, so too must the ...
Breaking Biology News(10 mins):